Naseem Ali, medical affairs lead for XTANDI at Astellas Australia, said, “Prostate cancer is currently the most diagnosed cancer in Australia and continues to be a major health burden, but these findings signal a meaningful step forward in improving outcomes for men facing the disease."
Australian-led ENZAMET prostate cancer trial to be presented at ASCO 2025
May 27, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
Specialised Therapeutics expands partnership with Incyte to include two additional therapies
June 13, 2025 - - Latest News -
New immunisation strategy highlights COVID impact, priority patients and new technologies
June 12, 2025 - - Latest News -
Medicines Australia establishes radiopharmaceuticals working group
June 12, 2025 - - Latest News -
MSD Australia and New Zealand certified a 'Great Place to Work'
June 12, 2025 - - Latest News -
Specialised Therapeutics expands partnership with Incyte to include two additional therapies
June 12, 2025 - - Latest News -
Novo Nordisk partners with Heart of Australia to expand clinical trial access
June 12, 2025 - - Latest News -
Mark Butler starts the process of NDIS pricing reform
June 11, 2025 - - Latest News